Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Kimia Biosciences Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Kimia Biosciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Kimia Biosciences - Board Meeting Outcome for Outcome Of Board Meeting Dated 29.08.2025

    29 Aug 2025, 6:19PM 1. Approval of the Annual Report for the Financial Year 2024-25.\r\n2. Approval of notice of 32nd AGM and fixation of day, date, time and venue of the
  • Kimia Biosciences - Board Meeting Intimation for Board Meeting To Be Held On Friday, August 29, 2025

    26 Aug 2025, 6:36PM Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2025 ,inter alia, to consider an
  • Kimia Biosciences - Revised Outcome Of Board Meeting Dated 14.08.2025

    21 Aug 2025, 5:03PM It is hereby submitted that revised outcome of Board Meeting is being filed here with reference to the previously filed outcome of Board Meeting vide
  • Kimia Biosciences - Announcement under Regulation 30 (LODR)-Change in Management

    14 Aug 2025, 6:09PM Appointment of CFO
  • Kimia Biosciences - Board Meeting Outcome for Board Meeting Outcome For Board Meeting Held Today On 14 Auguest,2025

    14 Aug 2025, 2:41PM Outcome of Board Meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.
  • Kimia Biosciences Q1 net profit down 58.33% at Rs 0.60 cr

    14 Aug 2025, 2:30PM The company reported standalone net profit of Rs 0.60 crore for the quarter ended June 30, 2025 as compared to Rs 1.44 crore in the same period last y
  • Kimia Biosciences - Financial Results For The Quarter Ended June 30, 2025

    14 Aug 2025, 1:58PM Financial Results for the quarter ended June 30, 2025
  • Kimia Biosciences - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of SEBI (Listing Obligati

    8 Aug 2025, 6:31PM Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider an
  • Kimia Biosciences - Disclosure under Regulation 30A of LODR

    4 Aug 2025, 6:07PM Disclosure under Regulation 30A of LODR-Clarification regarding inadvertent reference to SEBI in Warning letter communication .
  • Kimia Biosciences - Disclosure under Regulation 30A of LODR

    31 Jul 2025, 6:28PM Disclosure under Regulation 30A of SEBI (Listing Obligation and Disclosure Requirement)Regulations 2015
  • Kimia Biosciences - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    24 Jul 2025, 7:12PM DECLARATION OF RESULT OF REMOTE E-VOTING AND E-VOTING CONDUCTED DURING THE EXTRA-ORDINARY GENERAL MEETING HELD ON TUESDAY 22 JULY,2025 ALONG WITH THE
  • Kimia Biosciences has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    19 Jul 2025, 4:50PM As of June 2025, 74.94% is owned by Indian Promoters and 25.06% by Public. <p align=justify> Top Promoter holding highest number of shares of Kimia Bi
  • Kimia Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    10 Jul 2025, 9:50AM Compliance-Certificate under Regulation 74(5) of SEBI(DP) Regulation 2018
  • Kimia Biosciences - ANNOUNCEMENT UNDER REGULATION 30(LODR) REGARDING THE CLARIFICAION -PRICE MOVEMENT

    2 Jul 2025, 12:52PM Announcement Under Regulation 30(LODR) regarding the Clarification on Price Movement.
  • Kimia Biosciences - Clarification sought from Kimia Biosciences Ltd

    2 Jul 2025, 12:32PM The Exchange has sought clarification from Kimia Biosciences Ltd on July 2, 2025, with reference to Movement in Price.<BR><BR>The reply is awaited.
  • Kimia Biosciences - Intimation Of Newspaper Advertisement Of Extraordinary General Meeting And E-Voting Information.\r\n

    1 Jul 2025, 3:14PM Intimation of Newspaper advertisement of Extra-Ordinary General Meeting and E-Voting.
  • Kimia Biosciences - INTIMATION FOR THE APPOINTMENT OF INTERNAL AUDITOR FOR THE FINANCIAL YEAR 2025-2026

    25 Jun 2025, 5:36PM INTIMATION FOR THE APPOINTMENT OF INTERNAL AUDITOR FOR THE FINANCIAL YEAR 2025-2026 AS PER SEBI(LODR)REGULATION 2015
  • Kimia Biosciences - INTIMATION FOR THE APPOINTMENT OF SECRETARIAL AUDITOR FOR THE FINANCIAL YEAR 2024-2025

    25 Jun 2025, 5:34PM INTIMATION FOR THE APPOINTMENT OF SECRETARIAL AUDITOR FOR THE FINANCIAL YEAR 2024-2025
  • Kimia Biosciences - INTIMATION FOR THE APPOINTMENT OF ADDITIONAL DIRECTOR ,REGULARISATION WILL BE DONE IN ENSUING EGM SCHEDUL

    25 Jun 2025, 5:31PM INTIMATION FOR THE APPOINTMENT OF ADDITIONAL DIRECTOR
  • Kimia Biosciences - INTIMATION FOR THE APPOINTMENT OF COST AUDITOR

    25 Jun 2025, 5:28PM INTIMATION FOR THE APPOINTMENT OF COST AUDITOR FOR THE FINANCIAL YEAR 2025-2026 AS PER REGULATION 30 OF SEBI(LODR) REGULATIION 2015
  • Kimia Biosciences - Disclosure under Regulation 30A of LODR

    25 Jun 2025, 5:00PM Intimation of appointment of internal auditor for the financial year 2025-2026 as per the regulation 30 of SEBI(LODR)Regulation 2015
  • Kimia Biosciences - Disclosure under Regulation 30A of LODR

    25 Jun 2025, 4:56PM Intimation regarding the appointment of secretarial auditor for the financial year 2024-2025 as per the SEBI (LODR),regulation 2015
  • Kimia Biosciences - Disclosure under Regulation 30A of LODR

    25 Jun 2025, 4:54PM Intimation regarding the appointment of Additional director who will the regularised in the ensuing EGM which is going to be held on 22 july,2025
  • Kimia Biosciences - Disclosure under Regulation 30A of LODR

    25 Jun 2025, 4:51PM Intimation about the appointment of Cost Auditor of the company for the financial year 2025-2026.
  • Kimia Biosciences - Board Meeting Outcome for Board Meeting Outcome As Per Regulation 30SEBI(LODR)

    25 Jun 2025, 4:48PM BOARD MEETING OUCTOME AS PER REGULATION 30SEBI(LODR)
  • Kimia Biosciences - Reg. 34 (1) Annual Report.

    24 Jun 2025, 9:49PM Pursuant to Regulation 34 of SEBI(LODR)Regulations 2015,Submission of Annual Report for the financial Year 2023-2024 along with the Notice of 31st Ann

Key fundamentals

Evaluate the intrinsic value of Kimia Biosciences Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 49.5394 63.7096 55.5039 59.9092 44.0018
Liabilities 49.5394 63.7096 55.5039 59.9092 44.0018
Equity 4.7313 4.7313 4.7313 4.7313 4.6354
Gross Profit -0.4834 -4.9759 0.6314 8.3787 4.4512
Net Profit -5.3087 -9.3522 -3.703 5.1043 1.381
Cash From Operating Activities 14.5348 -6.77 0 5.967 0.3085
NPM(%) -5.06 -7.27 -2.96 3.84 1.29
Revenue 104.8765 128.516 124.9009 132.7138 106.2863
Expenses 105.3599 133.4919 124.2695 124.3351 101.8351
ROE(%) -53.26 -93.84 -37.15 51.21 13.85

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Kimia Biosciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 801.00 -1.01 72.72 21.39 301.39 0.62
Lotus Eye Hospital and Institute Ltd 119.50 -2.85 389.61 77.94 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 22.01 0.23 0.00 161.84 -39.50 0.00
Astec Lifesciences Ltd 823.00 -1.44 0.00 73.50 -604.77 0.00

Company Info

Laurel Organics Ltd. is a Public limited company, was incorporated in September 1993 in district Gurgaon, Haryana (India). 2017 NCLT approved the Scheme of Arrangement for Amalgamation of Kimia Biosciences Limited (Transferor Company) with Laurel Organics Limited (Transferee Company) 2019 -Company name has changed to Kimia Biosciences Ltd. from Laurel Organics Ltd.. 2024 -Kimia Biosciences Limited has been awarded a contract by a reputed client based in Europe. The Total Value of the Contract is USD 200,000/-

Laurel Organics Ltd. is a Public limited company, was incorporated in September 1993 in district Gurgaon, Haryana (India). 2017 NCLT approved the Scheme of Arrangement for Amalgamation of Kimia Biosciences Limited (Transferor Company) with Laurel Organics Limited (Transferee Company) 2019 -Company name has changed to Kimia Biosciences Ltd. from Laurel Organics Ltd.. 2024 -Kimia Biosciences Limited has been awarded a contract by a reputed client based in Europe. The Total Value of the Contract is USD 200,000/-

Read More

Parent Organisation

Kimia Biosciences Ltd.

Founded

27/09/1993

Managing Director

Mr.Sameer Goel

NSE Symbol

FAQ

The current price of Kimia Biosciences Ltd is

The 52-week high for Kimia Biosciences Ltd is

The market capitalization of Kimia Biosciences Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Kimia Biosciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Kimia Biosciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Kimia Biosciences Ltd shares.

The CEO of Kimia Biosciences Ltd is Mr.Sameer Goel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT